Old age, high risk medication, polypharmacy: a trilogy of risks in older patients with atrial fibrillation | Zendy

Yishen Wang | Zendy; Shamsher Singh | Zendy; Beata Bajorek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Old age, high risk medication, polypharmacy: a trilogy of risks in older patients with atrial fibrillation

Author(s) -

Yishen Wang,

Shamsher Singh,

Beata Bajorek

Publication year - 2016

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2016.02.706

Subject(s) - polypharmacy , medicine , atrial fibrillation , cohort , intensive care medicine , emergency medicine

Polypharmacy affects oldest AF patients, comprising medications that are indicated for AF, yet regarded as PIMs. Patients with lower risk of bleeding, obstructive pulmonary diseases, upper gastrointestinal diseases and poor physical function are also at higher risk of using higher number of medications. This may lead to an increased risk for medication misadventure due to the concomitant use of polypharmacy and medications for AF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research